Cabozantinib (XL184) in Patients With Relapsed or Refractory Myeloma
Clinical trial NCT01866293 · COMPLETED
Trial details
- NCT number
- NCT01866293
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-28
- Primary completion
- 2016-08-18
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.